Biosimilar Newsletter Archive

  1. 09.19.24 -- Advancing Drug Delivery: Safety, Reliability, And Innovation 9/19/2024

    09/19/24 Biosimilar Development Newsletter

  2. 09.19.24 -- The Influence Of Flows In cGMP Architectural Design 9/19/2024
    09/19/24 Biosimilar Development Newsletter
  3. 09.18.24 -- Let's Deviate From Deviations - Sterile Drugs. 9/18/2024

    09/18/24 Biosimilar Development Newsletter

  4. 09.12.24 -- Get The Most Out Of Your Filtration Processes 9/12/2024

    09/12/24 Biosimilar Development Newsletter

  5. 09.12.24 -- FDA Issues Draft Guidance On Use-Related Risk Analysis 9/12/2024
    09/12/24 Biosimilar Development Newsletter
  6. 09.11.24 -- All Eyes On Sustainability 9/11/2024

    09/11/24 Biosimilar Development Newsletter

  7. 09.05.24 -- Why Pharma 4.0 May Not Be Optional For Much Longer 9/5/2024
    09/05/24 Biosimilar Development Newsletter
  8. 08.29.24 -- Wearable Injectors: An Alternative To Traditional Intravenous Administration 8/29/2024
    08/29/24 Biosimilar Development Newsletter
  9. 08.28.24 -- Evolving Design Space Requirements For Biologic Combination Products 8/28/2024

    08/28/24 Biosimilar Development Newsletter

  10. 08.22.24 -- Draft Guidance Offers Biosimilar Post-Approval Change Roadmap 8/22/2024
    08/22/24 Biosimilar Development Newsletter